{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:18:03Z","timestamp":1792171083591,"version":"4.4.0"},"update-to":[{"DOI":"10.1002\/14651858.cd007893","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2010,1,20]],"date-time":"2010-01-20T00:00:00Z","timestamp":1263945600000}}],"reference-count":74,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd007893.pub2","type":"journal-article","created":{"date-parts":[[2010,1,18]],"date-time":"2010-01-18T15:20:40Z","timestamp":1263828040000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Effect of cyclosporine on blood pressure"],"prefix":"10.1002","volume":"2010","author":[{"given":"Nad\u00e8ge","family":"Robert","sequence":"first","affiliation":[{"name":"University of Bern; Institut of Social and Preventive Medicine; Finkenhubelweg 11 Bern Bern Switzerland CH-3012"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin WK","family":"Wong","sequence":"additional","affiliation":[{"name":"University of British Columbia; Department of Anesthesiology, Pharmacology and Therapeutics; 2176 Health Sciences Mall Vancouver BC Canada V6T 1Z3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M","family":"Wright","sequence":"additional","affiliation":[{"name":"University of British Columbia; Department of Anesthesiology, Pharmacology and Therapeutics; 2176 Health Sciences Mall Vancouver BC Canada V6T 1Z3"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,1,20]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD007893.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1006\/mvre.2000.2247","article-title":"Each administration of cyclosporin A enhances skin microvascular reactivity in renal transplant recipients","volume":"60","author":"Asberg","year":"2000","journal-title":"Microvascular research"},{"issue":"11","key":"10.1002\/14651858.CD007893.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/rheumatology\/35.11.1142","article-title":"Adding low-dose cyclosporin A to parenteral gold therapy in rheumatoid arthritis: a double-blind placebo-controlled study","volume":"35","author":"Bendix","year":"1996","journal-title":"British journal of rheumatology"},{"issue":"11 Pt 1","key":"10.1002\/14651858.CD007893.pub2-BIB0003|cit3","first-page":"1371","article-title":"Lack of effect of a single oral dose of cyclosporine on systemic blood pressure and on forearm blood flow and vascular resistance in humans","volume":"11","author":"Lima","year":"1998","journal-title":"American Journal of Hypertension : Journal of the American Society of Hypertension"},{"issue":"2","key":"10.1002\/14651858.CD007893.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/ard.47.2.127","article-title":"Cyclosporin in rheumatoid arthritis: a double blind, placebo controlled study in 52 patients","volume":"47","author":"Dougados","year":"1988","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"22","key":"10.1002\/14651858.CD007893.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1001\/jama.1986.03380220076026","article-title":"Cyclosporine Improves Psoriasis in a Double-blind Study","volume":"256","author":"Ellis","year":"1986","journal-title":"JAMA"},{"issue":"5","key":"10.1002\/14651858.CD007893.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1056\/NEJM199101313240501","article-title":"Cyclosporine for plaque-type psoriasis. Results of a multidose, double-blind trial","volume":"324","author":"Ellis","year":"1991","journal-title":"The New England journal of medicine"},{"issue":"8","key":"10.1002\/14651858.CD007893.pub2-BIB0007|cit7","first-page":"486","article-title":"Results of cyclosporin treatment of severe, chronic psoriasis vulgaris. (German)","volume":"40","author":"Engst","year":"1989","journal-title":"Hautarzt"},{"issue":"3","key":"10.1002\/14651858.CD007893.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00004872-199715030-00014","article-title":"Cyclosporine-induced hypertension and decline in renal function in healthy volunteers","volume":"15","author":"Hansen","year":"1997","journal-title":"Journal of hypertension"},{"issue":"2","key":"10.1002\/14651858.CD007893.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1164\/ajrccm.153.2.8564089","article-title":"Double-blind, placebo-controlled study of cyclosporin A as a corticosteroid-sparing agent in corticosteroid-dependent asthma","volume":"153","author":"Lock","year":"1996","journal-title":"American journal of respiratory and critical care medicine"},{"issue":"5","key":"10.1002\/14651858.CD007893.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/0016-5085(88)90373-3","article-title":"Pilot study of cyclosporin A in patients with symptomatic primary biliary cirrhosis","volume":"95","author":"Minuk","year":"1988","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1002\/14651858.CD007893.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1183\/09031936.95.08071091","article-title":"Treatment of steroid-dependent bronchial asthma with cyclosporin","volume":"8","author":"Nizankowska","year":"1995","journal-title":"The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology"},{"issue":"10","key":"10.1002\/14651858.CD007893.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1001\/archderm.1993.01680310043006","article-title":"Cyclosporine in the treatment of palmoplantar pustulosis. A randomized, double-blind, placebo-controlled study","volume":"129","author":"Reitamo","year":"1993","journal-title":"Archives of Dermatology"},{"issue":"8760","key":"10.1002\/14651858.CD007893.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0140-6736(91)90134-B","article-title":"Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis","volume":"338","author":"Sowden","year":"1991","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD007893.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/ki.1994.159","article-title":"Sequential effects of cyclosporine therapy on blood pressure, renal function and neurohormones","volume":"45","author":"Sturrock","year":"1994","journal-title":"Kidney international"},{"issue":"6","key":"10.1002\/14651858.CD007893.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/00004872-199506000-00014","article-title":"Serial changes in blood pressure, renal function, endothelin and lipoprotein (a) during the first 9 days of cyclosporin therapy in males","volume":"13","author":"Sturrock","year":"1995","journal-title":"Journal of hypertension"},{"issue":"8697","key":"10.1002\/14651858.CD007893.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/0140-6736(90)92630-Z","article-title":"Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis","volume":"335","author":"Tugwell","year":"1990","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD007893.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/ana.410270603","article-title":"Efficacy and toxicity of cyclosporine in chronic progressive multiple sclerosis: A randomized, double-blinded, placebo-controlled clinical trial","volume":"27","author":"Wolinsky","year":"1990","journal-title":"Annals of Neurology"},{"issue":"4","key":"10.1002\/14651858.CD007893.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1001\/archneur.1988.00520280027011","article-title":"A double-blind study of the effectiveness of cyclosporine in amyotrophic lateral sclerosis","volume":"45","author":"Appel","year":"1988","journal-title":"Archives of Neurology"},{"issue":"6","key":"10.1002\/14651858.CD007893.pub2-BIB0019|cit19","first-page":"388","article-title":"A multicenter, randomized, double-blind, placebo-controlled, two-year trial to study the effect of nitrendipine on chronic renal transplant function","volume":"43","author":"Barenbrock","year":"1995","journal-title":"Clinical nephrology"},{"issue":"10","key":"10.1002\/14651858.CD007893.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1093\/ndt\/6.10.725","article-title":"Effects of isradipine on renal function in cyclosporin-treated renal transplanted patients","volume":"6","author":"Berg","year":"1991","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD007893.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1046\/j.1523-1755.2000.00838.x","article-title":"Renal hemodynamics and pharmacokinetics of bosentan with and without cyclosporine A","volume":"57","author":"Binet","year":"2000","journal-title":"Kidney international"},{"issue":"7","key":"10.1002\/14651858.CD007893.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/gut.31.7.795","article-title":"Plasma interleukin-2 and a soluble\/shed interleukin-2 receptor in serum of patients with Crohn's disease. Effect of cyclosporin","volume":"31","author":"Brynskov","year":"1990","journal-title":"Gut"},{"issue":"7","key":"10.1002\/14651858.CD007893.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1097\/00007890-199704150-00025","article-title":"Isradipine for the prevention of cyclosporine-induced hpertension in allogeneic bone marrow transplant recipients: a randomized, double-blind study","volume":"63","author":"Bursztyn","year":"1997","journal-title":"Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD007893.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/00126334-200204010-00005","article-title":"Placebo-controlled trial of cyclosporin-A in HIV-1 disease: implications for solid organ transplantation","volume":"29","author":"Calabrese","year":"2002","journal-title":"Journal of acquired immune deficiency syndromes (1999)"},{"issue":"2","key":"10.1002\/14651858.CD007893.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2133.1993.tb03532.x","article-title":"Cyclosporin A in severe, therapy-resistant atopic dermatitis: report of an international workshop, April 1993","volume":"129","author":"Camp","year":"1993","journal-title":"British Journal of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD007893.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/ki.1995.161","article-title":"A controlled trial of cyclosporine in patients with progressive membranous nephropathy. Canadian Glomerulonephritis Study Group","volume":"47","author":"Cattran","year":"1995","journal-title":"Kidney international"},{"issue":"2","key":"10.1002\/14651858.CD007893.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1136\/ard.46.2.89","article-title":"Effect of cyclosporin A (CyA) on the immunopathological lesion of the labial minor salivary glands from patients with Sjogren's syndrome","volume":"46","author":"Dalavanga","year":"1987","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"6","key":"10.1002\/14651858.CD007893.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1136\/bjo.74.6.344","article-title":"Cyclosporin in the treatment of severe chronic idiopathic uveitis","volume":"74","author":"Vries","year":"1990","journal-title":"The British journal of ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD007893.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/BF00606627","article-title":"Effect of cyclosporin on serum creatinine in patients with rheumatoid arthritis","volume":"31","author":"Dijkmans van Rijthoven","year":"1987","journal-title":"European journal of clinical pharmacology"},{"issue":"9","key":"10.1002\/14651858.CD007893.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1136\/ard.45.9.732","article-title":"Cyclosporin A (CyA) in primary Sjogren's syndrome: a double blind study","volume":"45","author":"Drosos","year":"1986","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"6","key":"10.1002\/14651858.CD007893.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1046\/j.1365-2133.1998.02555.x","article-title":"Double-blind placebo-controlled study of long-term low-dose cyclosporin in the treatment of palmoplantar pustulosis","volume":"139","author":"Erkko","year":"1998","journal-title":"The British journal of dermatology"},{"issue":"26","key":"10.1002\/14651858.CD007893.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1056\/NEJM199406303302602","article-title":"Low-dose cyclosporine for the treatment of Crohn's disease","volume":"330","author":"Feagan","year":"1994","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD007893.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1365-2133.1990.tb02883.x","article-title":"Renal function and blood pressure in psoriatic patients treated with cyclosporin A","volume":"122 Suppl 36","author":"Feutren","year":"1990","journal-title":"The British journal of dermatology"},{"issue":"11","key":"10.1002\/14651858.CD007893.pub2-BIB0034|cit34","first-page":"291","article-title":"Erratum: Cyclosporin A monotherapy versus cyclosporin A and methotrexate combination therapy in patients with early rheumatoid arthritis: A double blind randomised placebo controlled trial (Annals of the Rheumatic Diseases (2003) 62 (291-296))","volume":"62","author":"Gerards AH Landewe RBM Prins APA Bruijn GAW Goei The HS","year":"2003","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"2","key":"10.1002\/14651858.CD007893.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1046\/j.1365-2133.2000.03664.x","article-title":"Randomized double-blind study of cyclosporin in chronic 'idiopathic' urticaria","volume":"143","author":"Grattan","year":"2000","journal-title":"The British journal of dermatology"},{"issue":"2","key":"10.1002\/14651858.CD007893.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1001\/archinte.1991.00400020106021","article-title":"Short-term changes in renal function, blood pressure, and electrolyte levels in patients receiving cyclosporine for dermatologic disorders","volume":"151","author":"Gupta","year":"1991","journal-title":"Archives of Internal Medicine"},{"issue":"8","key":"10.1002\/14651858.CD007893.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1097\/01.TP.0000137793.23371.42","article-title":"Calcium channel blockade and preservation of renal graft function in cyclosporine-treated recipients: A prospective randomized placebo-controlled 2-year study","volume":"78","author":"Kuypers","year":"2004","journal-title":"Transplantation"},{"issue":"6607","key":"10.1002\/14651858.CD007893.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1136\/bmj.295.6607.1165","article-title":"Cyclosporin treatment of IgA nephropathy: a short term controlled trial","volume":"295","author":"Lai","year":"1987","journal-title":"British Medical Journal Clinical Research Ed"},{"issue":"3","key":"10.1002\/14651858.CD007893.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF02550423","article-title":"Effect of cyclosporine A on circulating immune complexes in IgA nephropathy","volume":"23","author":"Lai","year":"1991","journal-title":"International Urology & Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD007893.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.amjcard.2007.03.058","article-title":"Prevention of renal dysfunction and hypertension by amlodipine after heart transplant","volume":"100","author":"Leenen","year":"2007","journal-title":"The American Journal of Cardiology"},{"issue":"1","key":"10.1002\/14651858.CD007893.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1681\/ASN.V7156","article-title":"A randomized double-blind placebo-controlled trial of cyclosporine in steroid-resistant idiopathic focal segmental glomerulosclerosis in children","volume":"7","author":"Lieberman","year":"1996","journal-title":"Journal of the American Society of Nephrology : JASN"},{"issue":"2","key":"10.1002\/14651858.CD007893.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0016-5085(93)90422-9","article-title":"Cyclosporin A treatment in primary biliary cirrhosis: results of a long-term placebo controlled trial","volume":"104","author":"Lombard","year":"1993","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1002\/14651858.CD007893.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3109\/00365519509110262","article-title":"Effect of felodipine on renal haemodynamics and tubular sodium handling after single-dose cyclosporin infusion in renal transplant recipients treated with azathioprine and prednisolone","volume":"55","author":"Madsen","year":"1995","journal-title":"Scandinavian journal of clinical and laboratory investigation"},{"issue":"3","key":"10.1002\/14651858.CD007893.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s002280050093","article-title":"Pharmacokinetic interaction between cyclosporine and the dihydropyridine calcium antagonist felodipine","volume":"50","author":"Madsen","year":"1996","journal-title":"European journal of clinical pharmacology"},{"issue":"6","key":"10.1002\/14651858.CD007893.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/BF00403182","article-title":"Follow-up of cyclosporin A treatment in type 1 (insulin-dependent) diabetes mellitus: lack of long-term effects","volume":"34","author":"Martin","year":"1991","journal-title":"Diabetologia"},{"issue":"10","key":"10.1002\/14651858.CD007893.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s00701-008-0021-7","article-title":"Brain metabolic and hemodynamic effects of cyclosporin A after human severe traumatic brain injury: A microdialysis study","volume":"150","author":"Mazzeo","year":"2008","journal-title":"Acta Neurochirurgica"},{"issue":"2","key":"10.1002\/14651858.CD007893.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2340\/0001555577137141","article-title":"Low-dose (1.25 mg\/kg) cyclosporin A: treatment of psoriasis and investigation of the influence on lipid profile","volume":"77","author":"Meffert","year":"1997","journal-title":"Acta Dermato-Venereologica"},{"issue":"1","key":"10.1002\/14651858.CD007893.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.arcmed.2003.07.008","article-title":"A randomized, double-blind, multicenter, controlled clinical trial of cyclosporine plus chloroquine vs. cyclosporine plus placebo in early-onset rheumatoid arthritis","volume":"35","author":"Miranda","year":"2004","journal-title":"Archives of Medical Research"},{"issue":"3","key":"10.1002\/14651858.CD007893.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1365-2133.1994.tb02936.x","article-title":"Maintenance treatment with cyclosporin in atopic eczema","volume":"130","author":"Munro","year":"1994","journal-title":"The British journal of dermatology"},{"issue":"9621","key":"10.1002\/14651858.CD007893.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/S0140-6736(08)60593-0","article-title":"Efficacy of ISA247 in plaque psoriasis: a randomised, multicentre, double-blind, placebo-controlled phase III study","volume":"371","author":"Papp","year":"2008","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD007893.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/01.TP.0000151006.86197.76","article-title":"Multicenter, randomized study of the effectiveness of basiliximab in avoiding addition of steroids to cyclosporine a monotherapy in renal transplant recipients","volume":"79","author":"Parrott","year":"2005","journal-title":"Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD007893.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1136\/jnnp.52.5.559","article-title":"Randomised double blind controlled trial of cyclosporin in multiple sclerosis","volume":"52","author":"Rudge","year":"1989","journal-title":"Journal of neurology, neurosurgery, and psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD007893.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1365-2133.1993.tb03170.x","article-title":"Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis. A randomized, double-blind, placebo-controlled trial","volume":"129","author":"Salek Finlay","year":"1993","journal-title":"The British journal of dermatology"},{"issue":"2","key":"10.1002\/14651858.CD007893.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1136\/gut.34.2.242","article-title":"Ulcerative colitis disease activity following treatment of associated primary sclerosing cholangitis with cyclosporin","volume":"34","author":"Sandborn","year":"1993","journal-title":"Gut"},{"issue":"5","key":"10.1002\/14651858.CD007893.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/thx.52.5.447","article-title":"Effect of cyclosporin A on the allergen-induced late asthmatic reaction","volume":"52","author":"Sihra Kon","year":"1997","journal-title":"Thorax"},{"issue":"3","key":"10.1002\/14651858.CD007893.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/0016-5085(95)90384-4","article-title":"European trial of cyclosporine in chronic active Crohn's disease: a 12-month study. The European Study Group","volume":"109","author":"Stange","year":"1995","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD007893.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2133.1988.tb01772.x","article-title":"Low-dose cyclosporin A in severe psoriasis. A double-blind study","volume":"118","author":"Joost","year":"1988","journal-title":"The British journal of dermatology"},{"issue":"5","key":"10.1002\/14651858.CD007893.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1365-2133.1994.tb13111.x","article-title":"Cyclosporin in atopic dermatitis: a multicentre placebo-controlled study","volume":"130","author":"Joost","year":"1994","journal-title":"The British journal of dermatology"},{"issue":"9","key":"10.1002\/14651858.CD007893.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1136\/ard.45.9.726","article-title":"Cyclosporin treatment for rheumatoid arthritis: A placebo controlled, double blind, multicentre study","volume":"45","author":"Rijthoven","year":"1986","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"4","key":"10.1002\/14651858.CD007893.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jaad.2006.04.078","article-title":"Cyclosporine in chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial","volume":"55","author":"Vena","year":"2006","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"20","key":"10.1002\/14651858.CD007893.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJM199005173222003","article-title":"A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis","volume":"322","author":"Wiesner","year":"1990","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD007893.pub2-BIB0062|cit62","first-page":"1034","article-title":"Isradipine for the prevention of cyclosporine-induced hypertension in allogeneic bone marrow transplant recipients: a randomized, double-blind study","volume":"63(7)","author":"Bursztyn M. Zelig O. Or R. Nagler","journal-title":"Transplantation"},{"key":"10.1002\/14651858.CD007893.pub2-BIB0063|cit63","first-page":"134","article-title":"Hypertension in cyclosporine-treated renal transplant recipients is sodium dependent","volume":"85(2)","author":"Curtis JJ. Luke RG. Jones P. Diethelm","year":"1988 Aug","journal-title":"\u00a0American Journal of Medicine"},{"key":"10.1002\/14651858.CD007893.pub2-BIB0064|cit64","volume-title":"Compendium of Pharmaceuticals and Specialties","volume":"online version","author":"Canadian Pharmacists Association","year":"2008"},{"key":"10.1002\/14651858.CD007893.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1126\/science.6334364","article-title":"Induction of interleukin 2 messenger RNA inhibited by cyclosporine A","volume":"226","author":"Elliott","year":"1984","journal-title":"Science"},{"issue":"1","key":"10.1002\/14651858.CD007893.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2165\/00128071-200102010-00007","article-title":"Cyclosporine in severe psoriasis. Results of a meta-analysis in 579 patients","volume":"2","author":"Faerber","year":"2001","journal-title":"American Journal of Clinical Dermatology"},{"key":"10.1002\/14651858.CD007893.pub2-BIB0067|cit67","first-page":"96","article-title":"Direct augmentation by cyclosporine A of vascular contractile response to nerve stimulation","volume":"9 (suppl 3)","author":"Golub","year":"1987","journal-title":"Hypertension"},{"issue":"4","key":"10.1002\/14651858.CD007893.pub2-BIB0068|cit68","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003823.pub2.","article-title":"Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension","author":"Heran","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD007893.pub2-BIB0069|cit69","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003822.pub2","article-title":"Blood pressure lowering efficacy of angiotensin receptor blockers for primary hypertension","author":"Heran","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD007893.pub2-BIB0070|cit70","first-page":"355","article-title":"Effect of cyclosporine A on human lymphocyte response in vitro. III. CyA inhibits the production of T lymphocyte growth factors in secondary mixed-lymphocyte responses but does not inhibit the response of primed lymphocytes to TCGF","volume":"128","author":"Hess","year":"1982","journal-title":"Immunol"},{"issue":"5","key":"10.1002\/14651858.CD007893.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"e5673","DOI":"10.1371\/journal.pone.0005673","article-title":"Factors affecting blood pressure variability: lessons learned from two systematic reviews of randomized controlled trials","volume":"4","author":"Musini","year":"2009","journal-title":"PLoS One"},{"key":"10.1002\/14651858.CD007893.pub2-BIB0072|cit72","first-page":"280","article-title":"Cyclosporine-associated hypertension","volume":"150(2)","author":"Porter","year":"1990 (Feb)","journal-title":"National High Blood Pressure Education Program. Archives of internal medicine"},{"key":"10.1002\/14651858.CD007893.pub2-BIB0073|cit73","first-page":"50","article-title":"Effect of isradipine on cyclosporin A-related hypertension","volume":"1","author":"Dorpel MA. Zietse R. Ijzermans JN. Schalekamp MA. Weimar","year":"1994","journal-title":"Blood Pressure Supplement"},{"key":"10.1002\/14651858.CD007893.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/00007890-198705000-00022","article-title":"Cyclosporine A induces constriction in isolated rat aorta","volume":"43","author":"Xue","year":"1987","journal-title":"Transplantation"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD007893.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:18:46Z","timestamp":1764548326000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD007893.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Hypertension Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2010,1,20]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2010,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007893.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,20]]}}}